Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Journal of Biological Sciences
  Year: 2008 | Volume: 8 | Issue: 3 | Page No.: 691-692
DOI: 10.3923/jbs.2008.691.692
VKORC1 Gene Analysis in an Iranian Warfarin Resistant Patient
P. Ghadam, F. Sadeghian, R. Sharifian, S. Sadrai, B. Kazemi and E. Nematipour

Abstract:
The vitamin K epoxide reductase subunit 1 (VKORC1) has been identified recently. It is a component of the enzyme vitamin K epoxide reductase that is the therapeutic target site of warfarin. In order to investigate the relationship between VKORC1 gene and warfarin dose response, we studied this gene in an Iranian warfarin resistant patient who receive more than 100 mg warfarin per day. The results showed that although warfarin concentration in his plasma was extremely higher than therapeutic level (22.8 mg L-1) but no mutation(s) found in the exons of VKORC1 gene. Other genes may be contributed in resistance to warfarin in this patient.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

P. Ghadam, F. Sadeghian, R. Sharifian, S. Sadrai, B. Kazemi and E. Nematipour, 2008. VKORC1 Gene Analysis in an Iranian Warfarin Resistant Patient. Journal of Biological Sciences, 8: 691-692.

DOI: 10.3923/jbs.2008.691.692

URL: https://scialert.net/abstract/?doi=jbs.2008.691.692

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 
 
 
 
 
 

       

       

Curve Bottom